Price T Rowe Associates Inc Roivant Sciences Ltd. Transaction History
Price T Rowe Associates Inc
- $869 Billion
- Q3 2024
A detailed history of Price T Rowe Associates Inc transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 273,631 shares of ROIV stock, worth $3.41 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
273,631
Previous 247,224
10.68%
Holding current value
$3.41 Million
Previous $2.61 Million
20.81%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ROIV
# of Institutions
311Shares Held
508MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$822 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$820 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$674 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$519 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$441 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.78B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...